Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review.
Raoufi E, Hemmati M, Eftekhari S, Khaksaran K, Mahmodi Z, Farajollahi MM, Mohsenzadegan M. Raoufi E, et al. Among authors: mohsenzadegan m. Int J Pept Res Ther. 2020;26(2):1155-1163. doi: 10.1007/s10989-019-09918-z. Epub 2019 Aug 20. Int J Pept Res Ther. 2020. PMID: 32435171 Free PMC article. Review.
Efficacy of immunotherapy in obese patients with cancer.
Mojibi Y, Seif F, Mojibi N, Aghamajidi A, Mohsenzadegan M, Torang HA. Mojibi Y, et al. Among authors: mohsenzadegan m. Immunopharmacol Immunotoxicol. 2022 Aug;44(4):471-483. doi: 10.1080/08923973.2022.2061989. Epub 2022 Apr 14. Immunopharmacol Immunotoxicol. 2022. PMID: 35369842 Review.
Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples.
Raoufi E, Hosseini F, Onagh B, Salehi-Shadkami M, Mehrali M, Mohsenzadegan M, Ho JQ, Bigdelou B, Sepand MR, Webster TJ, Zanganeh S, Farajollahi MM. Raoufi E, et al. Among authors: mohsenzadegan m. Clin Chim Acta. 2023 Mar 1;542:117279. doi: 10.1016/j.cca.2023.117279. Epub 2023 Mar 5. Clin Chim Acta. 2023. PMID: 36871661 Free PMC article.
A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency.
Sharifi L, Tavakolinia N, Kiaee F, Rezaei N, Mohsenzadegan M, Azizi G, Yazdani R, Shariat M, Mirshafiey A, Aghamohammadi A. Sharifi L, et al. Among authors: mohsenzadegan m. Endocr Metab Immune Disord Drug Targets. 2017;17(2):100-113. doi: 10.2174/1871530317666170613125009. Endocr Metab Immune Disord Drug Targets. 2017. PMID: 28641569 Review.
51 results